Collectively, these data demonstrate that overexpression and activation of PKCθ caused by PRKCQ amplification resulted in oncogenic activation of the TCR signaling pathway in the patient, setting the stage for the tumor-suppressive effect of PD-1 signaling in malignant T cells. This evidence concerns the gene PRKCQ and neoplasm.